Log In
Print
BCIQ
Print
Print this Print this
 

ALN-RSV01

Also known as: siRNA RSV

  Manage Alerts
Collapse Summary General Information
Company Alnylam Pharmaceuticals Inc.
DescriptionRespiratory syncytial virus (RSV)-specific small interfering RNA (siRNA)
Molecular Target RSV nucleocapsid gene
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPhase II
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsTreat and prevent respiratory syncytial virus (RSV); Treat respiratory syncytial virus (RSV) infection; Treat respiratory syncytial virus (RSV) infection in lung transplant patients
Regulatory Designation

Partner

Kyowa Hakko Kirin Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today